Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Payables: 2020-2023

Historic Payables for Candel Therapeutics (CADL) over the last 3 years, with Sep 2023 value amounting to $250,000.

  • Candel Therapeutics' Payables fell 74.23% to $250,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.7 million, marking a year-over-year decrease of 69.22%. This contributed to the annual value of $380,000 for FY2022, which is 76.10% down from last year.
  • As of Q3 2023, Candel Therapeutics' Payables stood at $250,000, which was down 47.92% from $480,000 recorded in Q2 2023.
  • Candel Therapeutics' 5-year Payables high stood at $1.6 million for Q4 2021, and its period low was $250,000 during Q3 2023.
  • Its 3-year average for Payables is $891,600, with a median of $842,000 in 2021.
  • Data for Candel Therapeutics' Payables shows a peak YoY increase of 108.70% (in 2022) and a maximum YoY decrease of 76.10% (in 2022) over the last 5 years.
  • Over the past 4 years, Candel Therapeutics' Payables (Quarterly) stood at $921,000 in 2020, then soared by 72.64% to $1.6 million in 2021, then tumbled by 76.10% to $380,000 in 2022, then crashed by 74.23% to $250,000 in 2023.
  • Its last three reported values are $250,000 in Q3 2023, $480,000 for Q2 2023, and $592,000 during Q1 2023.